D
David R. Staskin
Researcher at Tufts University
Publications - 203
Citations - 6148
David R. Staskin is an academic researcher from Tufts University. The author has contributed to research in topics: Overactive bladder & Urinary incontinence. The author has an hindex of 40, co-authored 194 publications receiving 5639 citations. Previous affiliations of David R. Staskin include American Urological Association & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Pelvic floor electrical stimulation in the treatment of genuine stress incontinence: A multicenter, placebo-controlled trial
Peter K. Sand,David A. Richardson,David R. Staskin,S E Swift,R A Appell,Kristene E. Whitmore,Donald R. Ostergard +6 more
TL;DR: Transvaginal pelvic floor electrical stimulation was found to be a safe and effective therapy for genuine stress incontinence in patients using active devices and controls.
Journal ArticleDOI
Update of AUA Guideline on the Surgical Management of Female Stress Urinary Incontinence
Roger Dmochowski,Jerry Blaivas,E. Ann Gormley,Saad Juma,Mickey M. Karram,Deborah J. Lightner,Karl M. Luber,Eric S. Rovner,David R. Staskin,J. Christian Winters,Rodney A. Appell +10 more
TL;DR: The surgical management of stress urinary incontinence with or without combined prolapse treatment continues to evolve and new technologies have emerged which have impacted surgical treatment algorithms.
Journal ArticleDOI
Prospective Randomized Controlled Trial of Extended-Release Oxybutynin Chloride and Tolterodine Tartrate in the Treatment of Overactive Bladder: Results of the OBJECT Study
Rodney A. Appell,Peter K. Sand,Roger R. Dmochowski,Rodney U. Anderson,Norman Zinner,Daniel J. Lama,Martha Roach,John R. Miklos,Daniel Saltzstein,Timothy B. Boone,David R. Staskin,Detlef Albrecht +11 more
TL;DR: Extended-release oxybutynin was more effective than tolterodine as measured by end-of-study urge incontinence, total incentinence, and micturition frequency episodes.
Journal ArticleDOI
Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study.
S. Grant Mulholland,S. Grant Mulholland,S. Grant Mulholland,Grannum R. Sant,Grannum R. Sant,Grannum R. Sant,Phillip M. Hanno,Phillip M. Hanno,Phillip M. Hanno,David R. Staskin,David R. Staskin,David R. Staskin,Lowell Parsons,Lowell Parsons,Lowell Parsons +14 more
TL;DR: In this study, Pentosan polysulfate sodium was found to be significantly more effective than, and equally as safe as, placebo and approached statistical significance.
Journal ArticleDOI
A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials
Annabel Nixon,Shoshana Colman,Luann Sabounjian,Bobby W. Sandage,Ute Schwiderski,David R. Staskin,Norman Zinner +6 more
TL;DR: IUSS is a validated patient reported measure of urgency severity for collecting event specific information in the context of a clinical trial and had a significant positive association with essential clinical and quality of life outcomes.